MPNs Explained: Key Tests at Diagnosis and Beyond
https://vimeo.com/1184889848 What exactly are myeloproliferative neoplasms (MPNs), and how do doctors diagnose and monitor them over time? MPN expert Dr. Shivani Handa breaks down the differences between essential thrombocytosis (ET),…
Self-Advocacy | Why In-Depth Cancer Testing Is Essential
https://vimeo.com/1143931847 Dr. Heidi Gray explains why speaking up and asking about in-depth cancer testing can make a real difference in understanding your cancer care. With today’s rapidly evolving testing options…
Molecular Testing and Hereditary Testing: What’s the Difference?
https://vimeo.com/1143931665 What is the difference between hereditary (genetic) testing and molecular testing in cancer care? Dr. Heidi Gray defines the tests in simple terms and shares how test results can…
When Should Someone With Cancer Undergo Molecular Testing?
https://vimeo.com/1133948722 Cancer researcher Dr. Paul Oberstein explains when patients should undergo molecular testing and why early testing can be crucial. Dr. Oberstein also discusses new methods like blood-based assays that…
What Is Molecular Testing and Why Is It Necessary in Cancer Care?
https://vimeo.com/1133948743 Dr. Paul Oberstein explains how molecular testing has revolutionized cancer care, providing doctors with an essential tool to personalize treatment and, in many cases, improve outcomes for people with…
Expert Advice for Finding an MPN Clinical Trial
https://vimeo.com/663119654 Dr. Andrew Kuykendall, an MPN specialist and researcher, shares tips for learning about available clinical trials. Dr. Kuykendall emphasizes the importance of seeking a consultation with a specialist and…
MPN Research and Optimism About Curative Therapies
https://vimeo.com/636610046 Myeloproliferative neoplasm (MPN) researcher Dr. John Mascarenhas discusses why he’s excited about the future of care for patients with essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF). Dr….
What To Expect When Starting MPN Inhibitor Therapy
https://vimeo.com/636610428 Changing a treatment approach for your essential thrombocythemia (ET), polycythemia vera (PV), or myelofibrosis (MF) can be intimidating. Dr. John Mascarenhas, a myeloproliferative neoplasm (MPN) specialist, shares tips and…
An Overview of ET, PV and MF Treatment Options
https://vimeo.com/636611502 Treatment for essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF) can vary greatly. Dr. John Mascarenhas breaks down the treatment types and the goals of treatment for each…
What Are the Benefits of MPN Inhibitor Treatment?
https://vimeo.com/636612929 MPN expert Dr. John Mascarenhas shares an overview of how inhibitor therapy works to treat myelofibrosis (MF) and the benefits of this type of treatment. Dr. John Mascarenhas is…
How Do MPNs Progress From One Disease to the Next?
https://vimeo.com/636617282 Understanding how essential thrombocythemia (ET), polycythemia vera (PV), or myelofibrosis (MF) are connected may be confusing to patients. Dr. John Mascarenhas, an expert in myeloproliferative neoplasms (MPNs), provides an…
Patient Considerations That Impact MPN Treatment Decisions
https://vimeo.com/636613669 How can personal choices play a role in your MPN care? Dr. John Mascarenhas reviews factors that should be considered, including lifestyle and overall health, when choosing therapy for…